tiprankstipranks
Revance Therapeutics (RVNC)
NASDAQ:RVNC

Revance Therapeutics (RVNC) Stock Investors

555 Followers
Based on 735,028 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RVNC
On average, investors allocate 4.25% of their portfolios to RVNC
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 735,028 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RVNC

1.2%
Last 7
Days
1.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RVNC, out of 735,028 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RVNC Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
2.38%
$9.31
Increased
0.09%
$8.08
Increased
3.50%
$3.02
Based on the activity of 13,851 investors who made their portfolios public
The table shows changes in RVNC in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RVNC Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
4.12%
-0.21%
-0.35%
332.28B
Healthcare
Applied Materials
4.84%
+1.70%
+4.42%
176.22B
Technology
Bristol-Myers Squibb
3.25%
+0.09%
+1.35%
89.25B
Healthcare
DraftKings
6.16%
-0.28%
+0.45%
38.43B
Consumer Cyclical
Baidu
4.94%
+3.21%
+12.31%
41.25B
Communication Services
ChargePoint Holdings
4.02%
-1.10%
-3.93%
808.62M
Consumer Cyclical
Citigroup
5.08%
-0.07%
-0.79%
122.21B
Financial
Micron
5.68%
+0.07%
+2.01%
138.74B
Technology
Devon Energy
5.48%
-1.19%
-4.46%
31.36B
Energy
Coherus Biosciences
2.58%
-1.18%
-5.64%
243.22M
Healthcare
Based on the activity of 735,028 active portfolios
Open your Smart Portfolio

RVNC Investor Analysis

RVNC investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.3%
of RVNC holders
are under 35
Average Segment Performance
Average P/E Ratio23.14
Beta6.02
Dividend Yield6.25%
RVNC investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
60.0%
of RVNC holders
are between 35–55
Average Segment Performance
Average P/E Ratio22.00
Beta10.67
Dividend Yield6.42%
RVNC investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.7%
of RVNC holders
are over 55
Average Segment Performance
Average P/E Ratio21.70
Beta3.83
Dividend Yield7.17%
Overview of age group and performance of RVNC stock investors
See who invests in RVNC according to age group and performance.

FAQ

How many retail Investors hold RVNC?
<0.1% of TipRanks' retail investors hold RVNC in their portfolios.
    What is RVNC Investor Sentiment?
    RVNC’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of RVNC in the last 7 days?
      ▲ 1.2% of TipRanks' retail investors changed their holding of RVNC in the last 7 days.
        What percentage of retail investors changed their holding of RVNC in the last 30 days?
        ▼ 1.6% of TipRanks' retail investors changed their holding of RVNC in the last 30 days.
          What is the average age of retail investors who hold RVNC?
          The average age of RVNC Holders is between 35–55.
            What other stocks have RVNC investors also bought?
            RVNC Investors also bought MRK, AMAT, BMY, DKNG, BIDU, CHPT, C, MU, DVN, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              BAXBaxter International
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis